PDC*line Pharma
La Tronche
About PDC*line Pharma
PDC*line Pharma is a clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of plasmacytoid dendritic cells (PDC*line) loaded with cancer antigens. It originated from a flagship R&D program of the blood bank, where PDC*line, a proprietary plasmacytoid dendritic cell line (PDC), was developed from a patient with a PDC leukemia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Total funding: $46.2M
- Funding stage: Early Stage Venture
- Last round: Series B (Dec 2021)
- Website: pdc-line-pharma.com
- Phone: +33 (0) 4 84 35 05 04
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/pdc-line-pharma-10050 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.